UCB S.A (UCB) | Stock Overview & Key Data
UCB S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €289.50 on February 19, 2026
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
UCB S.A
UCB
|
50.14B Large-cap | -0.69% | 9.37% | 1.69% | 8.86% | 10.67% | 68.19% | 220.47% | 222.73% | 332.23% | 618.13% | 618.13% |
|
Argenx SE
ARGX
|
41.43B Large-cap | -0.26% | 9.81% | 24.18% | 24.18% | 24.18% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% |
|
Onward Medical N.V
ONWD
|
204.41M Mid-cap | -3.62% | -3.97% | -26.92% | -34.00% | -39.41% | -37.17% | -55.89% | -79.43% | -79.43% | -79.43% | -79.43% |
| N/A | -1.22% | 14.47% | 5.09% | 6.07% | 7.58% | 85.71% | 225.88% | 200.37% | 364.29% | 681.77% | 681.77% | |
|
Hyloris
HYL
|
152.32M Mid-cap | -5.80% | -9.77% | -21.24% | -20.97% | -34.40% | -18.10% | -59.05% | -65.07% | -55.10% | -55.10% | -55.10% |
|
European Medical
ALEMS
|
20.74M Small-cap | 1.63% | 2.04% | 1.01% | -7.41% | 6.84% | 6.38% | -16.39% | -95.91% | -99.74% | -99.78% | -99.78% |
Calculate Your UCB S.A Investment Returns
Long-Term Investment Performance Analysis
UCB S.A stock price in Jul 2016 was €70.44, A €1,000.00 lump sum investment in UCB S.A made 9 years ago would be worth approximately €3,679.73 today, representing a outstanding return of 267.97%. This translates to an annualized return (CAGR) of 14.05%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is UCB's 52-week high and low?
- In the last 52 weeks, UCB S.A reached a high of €289.50 (on February 19, 2026) and a low of €153.65 (on June 19, 2025).
- What is the market cap and P/E ratio for UCB?
- Curious about UCB S.A's size and valuation? Its market capitalization stands at 50.14B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does UCB pay dividends? If so, what's the yield?
- Yes, UCB S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.90%, and the company has paid an average of €1.36 per share annually over the past 3 years.
- Who are UCB S.A's main competitors or similar companies to consider before investing?
When looking at UCB S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Argenx SE
ARGX41.43B Healthcare Biotechnology 29.01% 29.01% Onward Medical N.V
ONWD204.41M Healthcare Biotechnology -37.17% -55.89% Financière de Tubize
TUBN/A Healthcare Biotechnology 85.71% 225.88% Hyloris
HYL152.32M Healthcare Biotechnology -18.10% -59.05% European Medical
ALEMS20.74M Healthcare Biotechnology 6.38% -16.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for UCB S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of UCB S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for UCB?
- Looking at UCB S.A's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of UCB stock is held by insiders and institutions?
- Wondering who owns UCB S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.